Lots of news on the community pharmacy advocacy front this week, including mail order requirements, track and trace guidance, Part D lock-in programs, and more.

The Centers for Medicare & Medicaid Services (CMS) announced plans to delay the Federal Upper Limits (FUL) and the Final Rule on Covered Outpatient Drugs… again.

Recent price spikes for what were up until recently low-cost generic drugs prompted a Senate committee to look into the issue.

A federal advisory panel has recommended that greater transparency for pharmacy benefit managers be required in private health plans.

Midterm elections are sometimes regarded as a referendum on the sitting president's and/or incumbent party's performance. They usually don't turn out well for the party of the president.